embryonic stem cell

University of Michigan 6 new stem cell lines available for research

The Associated Press — Thu, 14 Jun 2012 15:28:08 +0000

ANN ARBOR, Mich. (AP) - Six new human embryonic stem cell lines derived at the University of Michigan are available for federal research.

University of Michigan Health System officials say in a release Thursday that researchers can begin using the stem cell lines to study the origins of diseases and potential treatments. U-M now has eight cell lines on the U.S. National Institutes of Health's registry, including five that carry genetic mutations for serious diseases including hemophilia B, Huntington's disease and hypertrophic cardiomyopathy.

Judge tosses out lawsuit against federal funding of embryonic stem cell research

Steve Carmody — Wed, 27 Jul 2011 18:24:50 +0000

Embryonic stem cell research at the University of Michigan is an indirect winner in a federal court decision. A U.S. District judge today tossed out a lawsuit challenging federal funding for the controversial medical research.

Governor, lawmakers spar over stem cell mandate

Rick Pluta — Thu, 23 Jun 2011 21:00:15 +0000

Some legislators are squaring off with Governor Rick Snyder and public universities over embryonic stem cell research. The governor says his administration won’t enforce a budget clause that says researchers must produce detailed reports on their work, and how they go about it. The universities say the rules outlined in the budgets are meant to stifle and discourage embryonic stem research.

U of M develops new embryonic stem cell lines for medical research

Steve Carmody — Mon, 04 Apr 2011 14:39:09 +0000

The University of Michigan has announced it has created new embryonic stem cell lines for medical research. Developing its own stem cell lines has been an important goal of the university’s stem cell research center since its inception two years.

In a written statement, Gary Smith, co-director of the U-M Consortium for Stem Cell Therapies and leader of the cell-line derivation project, talked about the importance of this milestone for the consortium:

"All our efforts are finally starting to bear fruit...Creating disease-specific human embryonic stem cell lines has been a central goal of the consortium since it was formed two years ago, and now we've passed that milestone."

The stem cell lines carry genes responsible for a type of hemophilia and a neurological disorder. In the future, researchers at the University of Michigan hope to develop additional stem cell lines that will help with research into Huntington's disease, spinal muscular atrophy and Tay-Sachs.